Clinical Trial Update: A Pilot Phase II Study of Maintenance Cabozantinib Plus Pembrolizumab for Patients With Metastatic Squamous Non-Small Cell Lung Cancer (sqNSCLC) [Phase 2]

View source ↗

Summary

A pilot Phase II clinical trial is evaluating maintenance cabozantinib plus pembrolizumab for metastatic squamous non-small cell lung cancer; the study is curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer
• Squamous Cell Carcinoma of the Lung

Drugs mentioned

• Pembrolizumab (pembrolizumab)
• cabozantinib (cabozantinib)

Snippet

Sponsor: University of Illinois at Chicago | Conditions: Metastatic Squamous Non-Small Cell Lung Carcinoma | Phase 2 | Status: RECRUITING